Using spectrophotometry to determine in vitro turnover rates of peptides in plasma

Journal of Biochemical and Biophysical Methods

Volumn 58, Issue 2, 2004, Pages 139-151

  Fuglsang, Anders ^a   Nilsson, Dan ^b   Nyborg, Niels C B ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b CHR HANSEN A S   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Dipeptides; Ortho phthaldialdehyde; Plasma; Rats

Indexed keywords

DIPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDICATOR; MILK PROTEIN; PEPTIDE; PROLINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CURVE FITTING; DERIVATIZATION; HALF LIFE TIME; MALE; MATHEMATICAL MODEL; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PROTEIN METABOLISM; RAT; SPECTROPHOTOMETRY; TURNOVER TIME;

EID: 1242314819     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbbm.2003.10.004     Document Type: Article

References (15)

1. Aiken J.W., Vane J.R. The renin-angiotensin system: inhibition of converting enzyme in isolated tissues. Nature. 228:1970;30-34.
2. Vane J.R. The history of inhibitors of angiotensin converting enzyme. J. Physiol. Pharmacol. 50:1999;489-498.
3. Stier C.T. Jr., Chander P., Gutstein W.H., Levine S., Itskovitz H.D. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am. J. Hypertens. 4:1991;680-687.
4. Levy B.I., Michel J.B., Salzmann J.L., Poitevin P., Devissaguet M., Scalbert E.et al. Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats. Am. J. Cardiol. 71:1993;8E-16E.
5. Thybo N.K., Stephens N., Cooper A., Aalkjaer C., Heagerty A.M., Mulvany M.J. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension. 25:1995;474-481.
6. Zhao Q., Piot J.M. Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin. Neuropeptides. 31:1997;147-153.
7. Lantz I., Glamsta E.L., Talback L., Nyberg F. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett. 287:1991;39-41.
8. Nakamura Y., Yamamoto N., Sakai K., Okubo A., Yamazaki S., Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 78:1995;777-783.
9. Kunji E.R., Mierau I., Hagting A., Poolman B., Konings W.N. The proteolytic systems of lactic acid bacteria. Antonie Van Leeuwenhoek. 70:1996;187-221.
10. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 64:1996;767-771.
11. Yamamoto N., Akino A., Takano T. Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 58:1994;776-778.
12. Fuglsang A., Nilsson D., Nyborg N.C.B. Characterization of new milk derived inhibitors of angiotensin converting enzyme in vitro and in vivo. J. Enz. Inh. Med. Chem. 18:2003;407-412.
13. Kok R.J., Visser J., Moolenaar F., de-Zeeuw D., Meijer D.K. Bioanalysis of captopril: two sensitive high-performance liquid chromatographic methods with pre- or postcolumn fluorescent labeling. J. Chromatogr., B, Biomed. Sci. Appl. 693:1997;181-189.
14. Church F.C., Porter D.H., Catignani G.L., Swaisgood H.E. An o-phthalaldehyde spectrophotometric assay for proteinases. Anal. Biochem. 146:1985;343-348.
15. Shibanoki S., Weinberger S.B., Beniston D., Nudelman K.A., Schulteis G., Bennett E.L.et al. Hydrolysis of [Leu]enkephalin by chick plasma in vitro. J. Pharmacol. Exp. Ther. 256:1991;650-655.